These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 26365611)

  • 1. Altered hippocampal plasticity by prenatal kynurenine administration, kynurenine-3-monoxygenase (KMO) deletion or galantamine.
    Forrest CM; McNair K; Pisar M; Khalil OS; Darlington LG; Stone TW
    Neuroscience; 2015 Dec; 310():91-105. PubMed ID: 26365611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in synaptic transmission and protein expression in the brains of adult offspring after prenatal inhibition of the kynurenine pathway.
    Forrest CM; Khalil OS; Pisar M; McNair K; Kornisiuk E; Snitcofsky M; Gonzalez N; Jerusalinsky D; Darlington LG; Stone TW
    Neuroscience; 2013 Dec; 254():241-59. PubMed ID: 24076085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal inhibition of the tryptophan-kynurenine pathway alters synaptic plasticity and protein expression in the rat hippocampus.
    Forrest CM; Khalil OS; Pisar M; Darlington LG; Stone TW
    Brain Res; 2013 Apr; 1504():1-15. PubMed ID: 23353758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified neocortical and cerebellar protein expression and morphology in adult rats following prenatal inhibition of the kynurenine pathway.
    Pisar M; Forrest CM; Khalil OS; McNair K; Vincenten MC; Qasem S; Darlington LG; Stone TW
    Brain Res; 2014 Aug; 1576():1-17. PubMed ID: 24956103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal inhibition of the kynurenine pathway leads to structural changes in the hippocampus of adult rat offspring.
    Khalil OS; Pisar M; Forrest CM; Vincenten MC; Darlington LG; Stone TW
    Eur J Neurosci; 2014 May; 39(10):1558-71. PubMed ID: 24646396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal genotype determines kynurenic acid levels in the fetal brain: Implications for the pathophysiology of schizophrenia.
    Beggiato S; Notarangelo FM; Sathyasaikumar KV; Giorgini F; Schwarcz R
    J Psychopharmacol; 2018 Nov; 32(11):1223-1232. PubMed ID: 30354938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kynurenine 3-mono-oxygenase inhibitors attenuate post-ischemic neuronal death in organotypic hippocampal slice cultures.
    Carpenedo R; Meli E; Peruginelli F; Pellegrini-Giampietro DE; Moroni F
    J Neurochem; 2002 Sep; 82(6):1465-71. PubMed ID: 12354294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early developmental elevations of brain kynurenic acid impair cognitive flexibility in adults: reversal with galantamine.
    Alexander KS; Pocivavsek A; Wu HQ; Pershing ML; Schwarcz R; Bruno JP
    Neuroscience; 2013 May; 238():19-28. PubMed ID: 23395862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of neuronal kynurenine 3-monooxygenase mediates depression-like behavior in a mouse model of neuropathic pain.
    Laumet G; Zhou W; Dantzer R; Edralin JD; Huo X; Budac DP; O'Connor JC; Lee AW; Heijnen CJ; Kavelaars A
    Brain Behav Immun; 2017 Nov; 66():94-102. PubMed ID: 28709913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galantamine enhancement of long-term potentiation is mediated by calcium/calmodulin-dependent protein kinase II and protein kinase C activation.
    Moriguchi S; Shioda N; Han F; Yeh JZ; Narahashi T; Fukunaga K
    Hippocampus; 2009 Sep; 19(9):844-54. PubMed ID: 19253410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotoxic kynurenine metabolism is increased in the dorsal hippocampus and drives distinct depressive behaviors during inflammation.
    Parrott JM; Redus L; Santana-Coelho D; Morales J; Gao X; O'Connor JC
    Transl Psychiatry; 2016 Oct; 6(10):e918. PubMed ID: 27754481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kynurenine 3-monooxygenase deficiency induces depression-like behavior via enhanced antagonism of α7 nicotinic acetylcholine receptors by kynurenic acid.
    Mori Y; Mouri A; Kunisawa K; Hirakawa M; Kubota H; Kosuge A; Niijima M; Hasegawa M; Kurahashi H; Murakami R; Hoshi M; Nakano T; Fujigaki S; Fujigaki H; Yamamoto Y; Nabeshima T; Saito K
    Behav Brain Res; 2021 May; 405():113191. PubMed ID: 33607168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid.
    Harris CA; Miranda AF; Tanguay JJ; Boegman RJ; Beninger RJ; Jhamandas K
    Br J Pharmacol; 1998 May; 124(2):391-9. PubMed ID: 9641558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kynurenine 3-monooxygenase is implicated in antidepressants-responsive depressive-like behaviors and monoaminergic dysfunctions.
    Tashiro T; Murakami Y; Mouri A; Imamura Y; Nabeshima T; Yamamoto Y; Saito K
    Behav Brain Res; 2017 Jan; 317():279-285. PubMed ID: 27693848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal kynurenine exposure in rats: age-dependent changes in NMDA receptor expression and conditioned fear responding.
    Pershing ML; Phenis D; Valentini V; Pocivavsek A; Lindquist DH; Schwarcz R; Bruno JP
    Psychopharmacology (Berl); 2016 Oct; 233(21-22):3725-3735. PubMed ID: 27527585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal administration of morphine decreases CREBSerine-133 phosphorylation and synaptic plasticity range mediated by glutamatergic transmission in the hippocampal CA1 area of cognitive-deficient rat offspring.
    Yang SN; Huang LT; Wang CL; Chen WF; Yang CH; Lin SZ; Lai MC; Chen SJ; Tao PL
    Hippocampus; 2003; 13(8):915-21. PubMed ID: 14750654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptive and Behavioral Changes in Kynurenine 3-Monooxygenase Knockout Mice: Relevance to Psychotic Disorders.
    Erhardt S; Pocivavsek A; Repici M; Liu XC; Imbeault S; Maddison DC; Thomas MAR; Smalley JL; Larsson MK; Muchowski PJ; Giorgini F; Schwarcz R
    Biol Psychiatry; 2017 Nov; 82(10):756-765. PubMed ID: 28187857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute elevations of brain kynurenic acid impair cognitive flexibility: normalization by the alpha7 positive modulator galantamine.
    Alexander KS; Wu HQ; Schwarcz R; Bruno JP
    Psychopharmacology (Berl); 2012 Apr; 220(3):627-37. PubMed ID: 22038535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemically administered glucosamine-kynurenic acid, but not pure kynurenic acid, is effective in decreasing the evoked activity in area CA1 of the rat hippocampus.
    Robotka H; Németh H; Somlai C; Vécsei L; Toldi J
    Eur J Pharmacol; 2005 Apr; 513(1-2):75-80. PubMed ID: 15878711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kynurenine administered together with probenecid markedly inhibits pentylenetetrazol-induced seizures. An electrophysiological and behavioural study.
    Németh H; Robotka H; Kis Z; Rózsa E; Janáky T; Somlai C; Marosi M; Farkas T; Toldi J; Vécsei L
    Neuropharmacology; 2004 Nov; 47(6):916-25. PubMed ID: 15527825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.